Advisor Group Holdings, Inc. Spring Works Therapeutics, Inc. Transaction History
Advisor Group Holdings, Inc.
- $42.2 Billion
- Q3 2024
A detailed history of Advisor Group Holdings, Inc. transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 1,259 shares of SWTX stock, worth $49,126. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,259
Previous 1,458
13.65%
Holding current value
$49,126
Previous $54,000
25.93%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding SWTX
# of Institutions
238Shares Held
69.8MCall Options Held
144KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA6.71MShares$262 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$219 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.84MShares$150 Million4.54% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.52MShares$137 Million0.01% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$134 Million5.82% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.43B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...